Simulations Plus (NASDAQ:SLP) Sees Unusually-High Trading Volume – Time to Buy?

Simulations Plus, Inc. (NASDAQ:SLP) saw an uptick in trading volume on Thursday . 107,839 shares traded hands during trading, a decline of 20% from the previous session’s volume of 134,672 shares.The stock last traded at $28.09 and had previously closed at $27.58.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on SLP. StockNews.com downgraded shares of Simulations Plus from a “hold” rating to a “sell” rating in a report on Monday, November 4th. BTIG Research decreased their price target on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a research note on Thursday, October 24th. KeyCorp began coverage on shares of Simulations Plus in a research note on Monday, July 29th. They issued an “overweight” rating and a $47.00 price target on the stock. Stephens began coverage on shares of Simulations Plus in a research note on Friday, November 15th. They issued an “overweight” rating and a $39.00 price target on the stock. Finally, William Blair reissued an “outperform” rating on shares of Simulations Plus in a research note on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $51.40.

Simulations Plus Stock Up 6.1 %

The stock has a market capitalization of $587.05 million, a price-to-earnings ratio of 56.29 and a beta of 0.71. The company’s 50-day moving average is $30.86 and its 200-day moving average is $38.49.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The business had revenue of $18.70 million during the quarter, compared to analysts’ expectations of $19.73 million. During the same period last year, the business earned $0.18 earnings per share. The business’s revenue for the quarter was up 19.9% on a year-over-year basis. Sell-side analysts anticipate that Simulations Plus, Inc. will post 1.12 EPS for the current year.

Insider Buying and Selling at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $31.26, for a total value of $625,200.00. Following the completion of the transaction, the director now owns 3,481,592 shares in the company, valued at approximately $108,834,565.92. The trade was a 0.57 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders sold a total of 60,750 shares of company stock worth $1,905,655 over the last three months. Insiders own 20.90% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. First Horizon Advisors Inc. lifted its position in shares of Simulations Plus by 82.6% during the 3rd quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company’s stock worth $26,000 after buying an additional 370 shares during the last quarter. nVerses Capital LLC lifted its position in shares of Simulations Plus by 1,100.0% during the 3rd quarter. nVerses Capital LLC now owns 1,200 shares of the technology company’s stock worth $38,000 after buying an additional 1,100 shares during the last quarter. EntryPoint Capital LLC purchased a new stake in shares of Simulations Plus during the 1st quarter worth approximately $57,000. Quantbot Technologies LP purchased a new stake in shares of Simulations Plus during the 3rd quarter worth approximately $59,000. Finally, US Bancorp DE lifted its position in shares of Simulations Plus by 37.0% during the 3rd quarter. US Bancorp DE now owns 4,974 shares of the technology company’s stock worth $159,000 after buying an additional 1,343 shares during the last quarter. Institutional investors and hedge funds own 78.08% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.